Global Healthcare-associated Infectious Disease Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Healthcare-associated Infectious Disease Diagnostics market size is predicted to grow from US$ 25377 million in 2025 to US$ 34910 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
Healthcare-associated Infectious Disease Diagnostics refers to an in-vitro diagnostic product and technology system used to detect, identify, type, and clinically interpret infections that occur or spread in hospitals, long-term care facilities, ambulatory surgery centers, dialysis centers, intensive care units, and other healthcare settings. It uses diagnostic reagents, instruments, microbiology identification platforms, antimicrobial susceptibility testing, molecular testing, immunoassays, quality-control systems, and informatics tools to analyze pathogens, resistance genes, toxins, antigens, antibodies, or host inflammatory markers in blood, respiratory specimens, urine, wound secretions, catheter tips, cerebrospinal fluid, stool, and environmental samples. It serves hospital infection surveillance, severe infection diagnosis, antimicrobial stewardship, isolation decisions, outbreak tracing, and healthcare quality control, forming a critical infrastructure for improving patient safety, reducing healthcare-associated transmission, and optimizing anti-infective therapy.The average gross profit margin of this product is 53%.
Healthcare-associated infectious disease diagnostics is evolving from a traditional infection-control tool into a key segment supporting patient safety, hospital quality management, antimicrobial stewardship, and public health resilience. As intensive care, oncology therapy, interventional procedures, organ transplantation, dialysis, and long-term elderly care continue to expand, vulnerable patient populations are increasing, driving sustained demand for rapid identification of bloodstream infections, ventilator-associated infections, catheter-related infections, surgical site infections, urinary tract infections, and multidrug-resistant organisms. Government policies continue to strengthen infectious disease surveillance, healthcare infection prevention, and laboratory testing capacity, while hospital management is shifting from post-event response toward active screening, real-time monitoring, and data-driven early warning. For companies, this field combines high clinical value, strict compliance requirements, and long-term hospital customer stickiness, making it an important growth entry point for the integration of microbiology, molecular diagnostics, and informatics platforms.The core challenges of this industry lie in complex pathogens, diverse sample types, rapidly evolving resistance mechanisms, difficult clinical interpretation, and long hospital procurement decision chains. Healthcare-associated infections often involve bacteria, fungi, viruses, or mixed infections, and are frequently associated with resistance genes, low pathogen loads, and complicated underlying diseases, placing higher requirements on testing sensitivity, specificity, antimicrobial susceptibility consistency, and report interpretation. Microbiological culture has longer turnaround times, molecular testing faces higher cost and platform-adaptation requirements, while rapid testing must balance speed, accuracy, and clinical usability. At the same time, hospital-acquired infection diagnostics are strongly influenced by hospital budgets, healthcare cost control, tender policies, and clinical-department awareness. Companies must build barriers through clinical evidence, product stability, service responsiveness, and data-management capability.Downstream demand is shifting from passive sample submission toward active screening, rapid diagnosis, resistance monitoring, and closed-loop management. Large general and specialty hospitals focus on high-risk settings such as intensive care units, hematology departments, oncology departments, transplant centers, operating rooms, dialysis centers, and neonatal units. They aim to shorten diagnostic time, optimize isolation measures, and guide precise medication through rapid etiological testing, antimicrobial susceptibility testing, resistance gene detection, and infection-control data platforms. Primary hospitals and long-term care facilities need testing solutions that are easy to operate, clear in results, and suitable for initial screening. Independent clinical laboratories and regional testing centers emphasize batch testing, standardized workflows, and regional resistance surveillance. In the future, healthcare-associated infectious disease diagnostics will become a core node in hospital infection management, antimicrobial stewardship, and healthcare quality evaluation systems.
LPI (LP Information)' newest research report, the ?Healthcare-associated Infectious Disease Diagnostics Industry Forecast? looks at past sales and reviews total world Healthcare-associated Infectious Disease Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Healthcare-associated Infectious Disease Diagnostics sales for 2026 through 2032. With Healthcare-associated Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Healthcare-associated Infectious Disease Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Healthcare-associated Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Healthcare-associated Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Healthcare-associated Infectious Disease Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Healthcare-associated Infectious Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Healthcare-associated Infectious Disease Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Healthcare-associated Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Healthcare-associated Infectious Disease Diagnostics refers to an in-vitro diagnostic product and technology system used to detect, identify, type, and clinically interpret infections that occur or spread in hospitals, long-term care facilities, ambulatory surgery centers, dialysis centers, intensive care units, and other healthcare settings. It uses diagnostic reagents, instruments, microbiology identification platforms, antimicrobial susceptibility testing, molecular testing, immunoassays, quality-control systems, and informatics tools to analyze pathogens, resistance genes, toxins, antigens, antibodies, or host inflammatory markers in blood, respiratory specimens, urine, wound secretions, catheter tips, cerebrospinal fluid, stool, and environmental samples. It serves hospital infection surveillance, severe infection diagnosis, antimicrobial stewardship, isolation decisions, outbreak tracing, and healthcare quality control, forming a critical infrastructure for improving patient safety, reducing healthcare-associated transmission, and optimizing anti-infective therapy.The average gross profit margin of this product is 53%.
Healthcare-associated infectious disease diagnostics is evolving from a traditional infection-control tool into a key segment supporting patient safety, hospital quality management, antimicrobial stewardship, and public health resilience. As intensive care, oncology therapy, interventional procedures, organ transplantation, dialysis, and long-term elderly care continue to expand, vulnerable patient populations are increasing, driving sustained demand for rapid identification of bloodstream infections, ventilator-associated infections, catheter-related infections, surgical site infections, urinary tract infections, and multidrug-resistant organisms. Government policies continue to strengthen infectious disease surveillance, healthcare infection prevention, and laboratory testing capacity, while hospital management is shifting from post-event response toward active screening, real-time monitoring, and data-driven early warning. For companies, this field combines high clinical value, strict compliance requirements, and long-term hospital customer stickiness, making it an important growth entry point for the integration of microbiology, molecular diagnostics, and informatics platforms.The core challenges of this industry lie in complex pathogens, diverse sample types, rapidly evolving resistance mechanisms, difficult clinical interpretation, and long hospital procurement decision chains. Healthcare-associated infections often involve bacteria, fungi, viruses, or mixed infections, and are frequently associated with resistance genes, low pathogen loads, and complicated underlying diseases, placing higher requirements on testing sensitivity, specificity, antimicrobial susceptibility consistency, and report interpretation. Microbiological culture has longer turnaround times, molecular testing faces higher cost and platform-adaptation requirements, while rapid testing must balance speed, accuracy, and clinical usability. At the same time, hospital-acquired infection diagnostics are strongly influenced by hospital budgets, healthcare cost control, tender policies, and clinical-department awareness. Companies must build barriers through clinical evidence, product stability, service responsiveness, and data-management capability.Downstream demand is shifting from passive sample submission toward active screening, rapid diagnosis, resistance monitoring, and closed-loop management. Large general and specialty hospitals focus on high-risk settings such as intensive care units, hematology departments, oncology departments, transplant centers, operating rooms, dialysis centers, and neonatal units. They aim to shorten diagnostic time, optimize isolation measures, and guide precise medication through rapid etiological testing, antimicrobial susceptibility testing, resistance gene detection, and infection-control data platforms. Primary hospitals and long-term care facilities need testing solutions that are easy to operate, clear in results, and suitable for initial screening. Independent clinical laboratories and regional testing centers emphasize batch testing, standardized workflows, and regional resistance surveillance. In the future, healthcare-associated infectious disease diagnostics will become a core node in hospital infection management, antimicrobial stewardship, and healthcare quality evaluation systems.
LPI (LP Information)' newest research report, the ?Healthcare-associated Infectious Disease Diagnostics Industry Forecast? looks at past sales and reviews total world Healthcare-associated Infectious Disease Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Healthcare-associated Infectious Disease Diagnostics sales for 2026 through 2032. With Healthcare-associated Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Healthcare-associated Infectious Disease Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Healthcare-associated Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Healthcare-associated Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Healthcare-associated Infectious Disease Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Healthcare-associated Infectious Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Healthcare-associated Infectious Disease Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Healthcare-associated Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Sample
- Respiratory Sample
- Urine Sample
- Other
- Molecular Diagnostics
- Immunodiagnostics
- Culture & AST
- POCT Rapid Tests
- Other
- Respiratory Infections
- Hepatitis & Blood-borne
- Sexually Transmitted Infections
- Gastrointestinal Infections
- Other
- Public Hospitals
- Third-party Independent Laboratory
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Danaher
- Abbott
- bioM?rieux
- Hologic
- Thermo Fisher Scientific
- Roche
- DiaSorin
- QuidelOrtho
- Siemens Healthineers
- Qiagen
- Bio-Rad
- Wondfo Biotech
- Autobio
- Daan Gene
- Innovita
- Hybribio
- BioPerfectus
- Sansure
- Liferiver
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size (2021-2032)
2.1.2 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Healthcare-associated Infectious Disease Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Healthcare-associated Infectious Disease Diagnostics Segment by Type
2.2.1 Blood Sample
2.2.2 Respiratory Sample
2.2.3 Urine Sample
2.2.4 Other
2.2.5 Healthcare-associated Infectious Disease Diagnostics Market Size by Type
2.2.5.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Healthcare-associated Infectious Disease Diagnostics Segment by Technology
2.3.1 Molecular Diagnostics
2.3.2 Immunodiagnostics
2.3.3 Culture & AST
2.3.4 POCT Rapid Tests
2.3.5 Other
2.3.6 Healthcare-associated Infectious Disease Diagnostics Market Size by Technology
2.3.6.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.6.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
2.4 Healthcare-associated Infectious Disease Diagnostics Segment by Test Item
2.4.1 Respiratory Infections
2.4.2 Hepatitis & Blood-borne
2.4.3 Sexually Transmitted Infections
2.4.4 Gastrointestinal Infections
2.4.5 Other
2.4.6 Healthcare-associated Infectious Disease Diagnostics Market Size by Test Item
2.4.6.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032)
2.4.6.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
2.5 Healthcare-associated Infectious Disease Diagnostics Segment by Application
2.5.1 Public Hospitals
2.5.2 Third-party Independent Laboratory
2.5.3 Other
2.5.4 Healthcare-associated Infectious Disease Diagnostics Market Size by Application
2.5.4.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
3 HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Player
3.1.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS BY REGION
4.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.4 APAC Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.5 Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026)
5.2 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
5.3 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026)
6.2 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
6.3 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast
10.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.2 Canada Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.3 Mexico Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.4 Brazil Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.3.1 China Healthcare-associated Infectious Disease Diagnostics Market Forecast
10.3.2 Japan Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.3 Korea Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.4 Southeast Asia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.5 India Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.6 Australia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.2 France Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.3 UK Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.4 Italy Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.5 Russia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.2 South Africa Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.3 Israel Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.4 Turkey Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.6 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Type (2027-2032)
10.7 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Healthcare-associated Infectious Disease Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Healthcare-associated Infectious Disease Diagnostics Product Offered
11.1.3 BD Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
11.2.3 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
11.3.3 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Healthcare-associated Infectious Disease Diagnostics Product Offered
11.4.3 bioM?rieux Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Healthcare-associated Infectious Disease Diagnostics Product Offered
11.5.3 Hologic Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
11.6.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
11.7.3 Roche Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Healthcare-associated Infectious Disease Diagnostics Product Offered
11.8.3 DiaSorin Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 QuidelOrtho
11.9.1 QuidelOrtho Company Information
11.9.2 QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Product Offered
11.9.3 QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 QuidelOrtho Main Business Overview
11.9.5 QuidelOrtho Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Product Offered
11.10.3 Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Qiagen
11.11.1 Qiagen Company Information
11.11.2 Qiagen Healthcare-associated Infectious Disease Diagnostics Product Offered
11.11.3 Qiagen Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Qiagen Main Business Overview
11.11.5 Qiagen Latest Developments
11.12 Bio-Rad
11.12.1 Bio-Rad Company Information
11.12.2 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
11.12.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Main Business Overview
11.12.5 Bio-Rad Latest Developments
11.13 Wondfo Biotech
11.13.1 Wondfo Biotech Company Information
11.13.2 Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
11.13.3 Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Wondfo Biotech Main Business Overview
11.13.5 Wondfo Biotech Latest Developments
11.14 Autobio
11.14.1 Autobio Company Information
11.14.2 Autobio Healthcare-associated Infectious Disease Diagnostics Product Offered
11.14.3 Autobio Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Autobio Main Business Overview
11.14.5 Autobio Latest Developments
11.15 Daan Gene
11.15.1 Daan Gene Company Information
11.15.2 Daan Gene Healthcare-associated Infectious Disease Diagnostics Product Offered
11.15.3 Daan Gene Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Daan Gene Main Business Overview
11.15.5 Daan Gene Latest Developments
11.16 Innovita
11.16.1 Innovita Company Information
11.16.2 Innovita Healthcare-associated Infectious Disease Diagnostics Product Offered
11.16.3 Innovita Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Innovita Main Business Overview
11.16.5 Innovita Latest Developments
11.17 Hybribio
11.17.1 Hybribio Company Information
11.17.2 Hybribio Healthcare-associated Infectious Disease Diagnostics Product Offered
11.17.3 Hybribio Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Hybribio Main Business Overview
11.17.5 Hybribio Latest Developments
11.18 BioPerfectus
11.18.1 BioPerfectus Company Information
11.18.2 BioPerfectus Healthcare-associated Infectious Disease Diagnostics Product Offered
11.18.3 BioPerfectus Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BioPerfectus Main Business Overview
11.18.5 BioPerfectus Latest Developments
11.19 Sansure
11.19.1 Sansure Company Information
11.19.2 Sansure Healthcare-associated Infectious Disease Diagnostics Product Offered
11.19.3 Sansure Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sansure Main Business Overview
11.19.5 Sansure Latest Developments
11.20 Liferiver
11.20.1 Liferiver Company Information
11.20.2 Liferiver Healthcare-associated Infectious Disease Diagnostics Product Offered
11.20.3 Liferiver Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Liferiver Main Business Overview
11.20.5 Liferiver Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size (2021-2032)
2.1.2 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Healthcare-associated Infectious Disease Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Healthcare-associated Infectious Disease Diagnostics Segment by Type
2.2.1 Blood Sample
2.2.2 Respiratory Sample
2.2.3 Urine Sample
2.2.4 Other
2.2.5 Healthcare-associated Infectious Disease Diagnostics Market Size by Type
2.2.5.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Healthcare-associated Infectious Disease Diagnostics Segment by Technology
2.3.1 Molecular Diagnostics
2.3.2 Immunodiagnostics
2.3.3 Culture & AST
2.3.4 POCT Rapid Tests
2.3.5 Other
2.3.6 Healthcare-associated Infectious Disease Diagnostics Market Size by Technology
2.3.6.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.6.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
2.4 Healthcare-associated Infectious Disease Diagnostics Segment by Test Item
2.4.1 Respiratory Infections
2.4.2 Hepatitis & Blood-borne
2.4.3 Sexually Transmitted Infections
2.4.4 Gastrointestinal Infections
2.4.5 Other
2.4.6 Healthcare-associated Infectious Disease Diagnostics Market Size by Test Item
2.4.6.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032)
2.4.6.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
2.5 Healthcare-associated Infectious Disease Diagnostics Segment by Application
2.5.1 Public Hospitals
2.5.2 Third-party Independent Laboratory
2.5.3 Other
2.5.4 Healthcare-associated Infectious Disease Diagnostics Market Size by Application
2.5.4.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
3 HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Player
3.1.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS BY REGION
4.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.4 APAC Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.5 Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026)
5.2 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
5.3 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026)
6.2 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
6.3 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast
10.1.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast
10.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.2 Canada Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.3 Mexico Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.2.4 Brazil Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.3.1 China Healthcare-associated Infectious Disease Diagnostics Market Forecast
10.3.2 Japan Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.3 Korea Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.4 Southeast Asia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.5 India Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.3.6 Australia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.2 France Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.3 UK Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.4 Italy Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.4.5 Russia Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.2 South Africa Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.3 Israel Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.5.4 Turkey Market Healthcare-associated Infectious Disease Diagnostics Forecast
10.6 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Type (2027-2032)
10.7 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Healthcare-associated Infectious Disease Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Healthcare-associated Infectious Disease Diagnostics Product Offered
11.1.3 BD Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
11.2.3 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
11.3.3 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Healthcare-associated Infectious Disease Diagnostics Product Offered
11.4.3 bioM?rieux Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Healthcare-associated Infectious Disease Diagnostics Product Offered
11.5.3 Hologic Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
11.6.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
11.7.3 Roche Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Healthcare-associated Infectious Disease Diagnostics Product Offered
11.8.3 DiaSorin Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 QuidelOrtho
11.9.1 QuidelOrtho Company Information
11.9.2 QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Product Offered
11.9.3 QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 QuidelOrtho Main Business Overview
11.9.5 QuidelOrtho Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Product Offered
11.10.3 Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Qiagen
11.11.1 Qiagen Company Information
11.11.2 Qiagen Healthcare-associated Infectious Disease Diagnostics Product Offered
11.11.3 Qiagen Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Qiagen Main Business Overview
11.11.5 Qiagen Latest Developments
11.12 Bio-Rad
11.12.1 Bio-Rad Company Information
11.12.2 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
11.12.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Main Business Overview
11.12.5 Bio-Rad Latest Developments
11.13 Wondfo Biotech
11.13.1 Wondfo Biotech Company Information
11.13.2 Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
11.13.3 Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Wondfo Biotech Main Business Overview
11.13.5 Wondfo Biotech Latest Developments
11.14 Autobio
11.14.1 Autobio Company Information
11.14.2 Autobio Healthcare-associated Infectious Disease Diagnostics Product Offered
11.14.3 Autobio Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Autobio Main Business Overview
11.14.5 Autobio Latest Developments
11.15 Daan Gene
11.15.1 Daan Gene Company Information
11.15.2 Daan Gene Healthcare-associated Infectious Disease Diagnostics Product Offered
11.15.3 Daan Gene Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Daan Gene Main Business Overview
11.15.5 Daan Gene Latest Developments
11.16 Innovita
11.16.1 Innovita Company Information
11.16.2 Innovita Healthcare-associated Infectious Disease Diagnostics Product Offered
11.16.3 Innovita Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Innovita Main Business Overview
11.16.5 Innovita Latest Developments
11.17 Hybribio
11.17.1 Hybribio Company Information
11.17.2 Hybribio Healthcare-associated Infectious Disease Diagnostics Product Offered
11.17.3 Hybribio Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Hybribio Main Business Overview
11.17.5 Hybribio Latest Developments
11.18 BioPerfectus
11.18.1 BioPerfectus Company Information
11.18.2 BioPerfectus Healthcare-associated Infectious Disease Diagnostics Product Offered
11.18.3 BioPerfectus Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BioPerfectus Main Business Overview
11.18.5 BioPerfectus Latest Developments
11.19 Sansure
11.19.1 Sansure Company Information
11.19.2 Sansure Healthcare-associated Infectious Disease Diagnostics Product Offered
11.19.3 Sansure Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sansure Main Business Overview
11.19.5 Sansure Latest Developments
11.20 Liferiver
11.20.1 Liferiver Company Information
11.20.2 Liferiver Healthcare-associated Infectious Disease Diagnostics Product Offered
11.20.3 Liferiver Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Liferiver Main Business Overview
11.20.5 Liferiver Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Healthcare-associated Infectious Disease Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Sample
Table 4. Major Players of Respiratory Sample
Table 5. Major Players of Urine Sample
Table 6. Major Players of Other
Table 7. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Molecular Diagnostics
Table 11. Major Players of Immunodiagnostics
Table 12. Major Players of Culture & AST
Table 13. Major Players of POCT Rapid Tests
Table 14. Major Players of Other
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Technology (2021-2026) & ($ millions)
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
Table 18. Major Players of Respiratory Infections
Table 19. Major Players of Hepatitis & Blood-borne
Table 20. Major Players of Sexually Transmitted Infections
Table 21. Major Players of Gastrointestinal Infections
Table 22. Major Players of Other
Table 23. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Test Item (2021-2026) & ($ millions)
Table 25. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
Table 26. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
Table 31. Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
Table 32. Healthcare-associated Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Table 37. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
Table 41. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Table 43. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Table 45. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Table 47. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
Table 51. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Healthcare-associated Infectious Disease Diagnostics
Table 57. Key Market Challenges & Risks of Healthcare-associated Infectious Disease Diagnostics
Table 58. Key Industry Trends of Healthcare-associated Infectious Disease Diagnostics
Table 59. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. BD Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 64. BD Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 65. BD Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Danaher Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 69. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 70. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Danaher Main Business
Table 72. Danaher Latest Developments
Table 73. Abbott Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 74. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 75. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. bioM?rieux Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 79. bioM?rieux Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 80. bioM?rieux Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. bioM?rieux Main Business
Table 82. bioM?rieux Latest Developments
Table 83. Hologic Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 84. Hologic Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 85. Hologic Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hologic Main Business
Table 87. Hologic Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 90. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Roche Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 94. Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 95. Roche Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. DiaSorin Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 99. DiaSorin Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 100. DiaSorin Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. DiaSorin Main Business
Table 102. DiaSorin Latest Developments
Table 103. QuidelOrtho Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 104. QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 105. QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. QuidelOrtho Main Business
Table 107. QuidelOrtho Latest Developments
Table 108. Siemens Healthineers Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 109. Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 110. Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Siemens Healthineers Main Business
Table 112. Siemens Healthineers Latest Developments
Table 113. Qiagen Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 114. Qiagen Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 115. Qiagen Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Qiagen Main Business
Table 117. Qiagen Latest Developments
Table 118. Bio-Rad Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 119. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 120. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Rad Main Business
Table 122. Bio-Rad Latest Developments
Table 123. Wondfo Biotech Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 124. Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 125. Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Wondfo Biotech Main Business
Table 127. Wondfo Biotech Latest Developments
Table 128. Autobio Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 129. Autobio Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 130. Autobio Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Autobio Main Business
Table 132. Autobio Latest Developments
Table 133. Daan Gene Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 134. Daan Gene Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 135. Daan Gene Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Daan Gene Main Business
Table 137. Daan Gene Latest Developments
Table 138. Innovita Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 139. Innovita Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 140. Innovita Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Innovita Main Business
Table 142. Innovita Latest Developments
Table 143. Hybribio Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 144. Hybribio Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 145. Hybribio Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hybribio Main Business
Table 147. Hybribio Latest Developments
Table 148. BioPerfectus Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 149. BioPerfectus Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 150. BioPerfectus Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. BioPerfectus Main Business
Table 152. BioPerfectus Latest Developments
Table 153. Sansure Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 154. Sansure Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 155. Sansure Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Sansure Main Business
Table 157. Sansure Latest Developments
Table 158. Liferiver Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 159. Liferiver Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 160. Liferiver Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Liferiver Main Business
Table 162. Liferiver Latest Developments
Table 1. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Healthcare-associated Infectious Disease Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Sample
Table 4. Major Players of Respiratory Sample
Table 5. Major Players of Urine Sample
Table 6. Major Players of Other
Table 7. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Molecular Diagnostics
Table 11. Major Players of Immunodiagnostics
Table 12. Major Players of Culture & AST
Table 13. Major Players of POCT Rapid Tests
Table 14. Major Players of Other
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Technology (2021-2026) & ($ millions)
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
Table 18. Major Players of Respiratory Infections
Table 19. Major Players of Hepatitis & Blood-borne
Table 20. Major Players of Sexually Transmitted Infections
Table 21. Major Players of Gastrointestinal Infections
Table 22. Major Players of Other
Table 23. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Test Item (2021-2026) & ($ millions)
Table 25. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
Table 26. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
Table 31. Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
Table 32. Healthcare-associated Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Table 37. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
Table 41. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Table 43. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Table 45. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Table 47. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
Table 51. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Healthcare-associated Infectious Disease Diagnostics
Table 57. Key Market Challenges & Risks of Healthcare-associated Infectious Disease Diagnostics
Table 58. Key Industry Trends of Healthcare-associated Infectious Disease Diagnostics
Table 59. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. BD Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 64. BD Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 65. BD Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Danaher Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 69. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 70. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Danaher Main Business
Table 72. Danaher Latest Developments
Table 73. Abbott Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 74. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 75. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. bioM?rieux Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 79. bioM?rieux Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 80. bioM?rieux Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. bioM?rieux Main Business
Table 82. bioM?rieux Latest Developments
Table 83. Hologic Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 84. Hologic Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 85. Hologic Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hologic Main Business
Table 87. Hologic Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 90. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Roche Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 94. Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 95. Roche Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. DiaSorin Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 99. DiaSorin Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 100. DiaSorin Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. DiaSorin Main Business
Table 102. DiaSorin Latest Developments
Table 103. QuidelOrtho Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 104. QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 105. QuidelOrtho Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. QuidelOrtho Main Business
Table 107. QuidelOrtho Latest Developments
Table 108. Siemens Healthineers Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 109. Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 110. Siemens Healthineers Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Siemens Healthineers Main Business
Table 112. Siemens Healthineers Latest Developments
Table 113. Qiagen Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 114. Qiagen Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 115. Qiagen Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Qiagen Main Business
Table 117. Qiagen Latest Developments
Table 118. Bio-Rad Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 119. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 120. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Rad Main Business
Table 122. Bio-Rad Latest Developments
Table 123. Wondfo Biotech Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 124. Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 125. Wondfo Biotech Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Wondfo Biotech Main Business
Table 127. Wondfo Biotech Latest Developments
Table 128. Autobio Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 129. Autobio Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 130. Autobio Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Autobio Main Business
Table 132. Autobio Latest Developments
Table 133. Daan Gene Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 134. Daan Gene Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 135. Daan Gene Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Daan Gene Main Business
Table 137. Daan Gene Latest Developments
Table 138. Innovita Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 139. Innovita Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 140. Innovita Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Innovita Main Business
Table 142. Innovita Latest Developments
Table 143. Hybribio Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 144. Hybribio Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 145. Hybribio Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hybribio Main Business
Table 147. Hybribio Latest Developments
Table 148. BioPerfectus Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 149. BioPerfectus Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 150. BioPerfectus Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. BioPerfectus Main Business
Table 152. BioPerfectus Latest Developments
Table 153. Sansure Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 154. Sansure Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 155. Sansure Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Sansure Main Business
Table 157. Sansure Latest Developments
Table 158. Liferiver Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
Table 159. Liferiver Healthcare-associated Infectious Disease Diagnostics Product Offered
Table 160. Liferiver Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Liferiver Main Business
Table 162. Liferiver Latest Developments
LIST OF FIGURES
Figure 1. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Healthcare-associated Infectious Disease Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type in 2025
Figure 10. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology in 2025
Figure 11. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item in 2025
Figure 12. Healthcare-associated Infectious Disease Diagnostics in Public Hospitals
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Healthcare-associated Infectious Disease Diagnostics in Third-party Independent Laboratory
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market: Third-party Independent Laboratory (2021-2026) & ($ millions)
Figure 16. Healthcare-associated Infectious Disease Diagnostics in Other
Figure 17. Global Healthcare-associated Infectious Disease Diagnostics Market: Other (2021-2026) & ($ millions)
Figure 18. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2025
Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player in 2025
Figure 20. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 25. Americas Healthcare-associated Infectious Disease Diagnostics Value Market Share by Country in 2025
Figure 26. United States Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region in 2025
Figure 31. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 33. China Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country in 2025
Figure 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. United States Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Canada Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. China Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Japan Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Korea Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. India Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Australia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Germany Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. France Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. UK Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Italy Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Russia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Israel Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Healthcare-associated Infectious Disease Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type in 2025
Figure 10. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Technology in 2025
Figure 11. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Test Item in 2025
Figure 12. Healthcare-associated Infectious Disease Diagnostics in Public Hospitals
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Healthcare-associated Infectious Disease Diagnostics in Third-party Independent Laboratory
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market: Third-party Independent Laboratory (2021-2026) & ($ millions)
Figure 16. Healthcare-associated Infectious Disease Diagnostics in Other
Figure 17. Global Healthcare-associated Infectious Disease Diagnostics Market: Other (2021-2026) & ($ millions)
Figure 18. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2025
Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player in 2025
Figure 20. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
Figure 25. Americas Healthcare-associated Infectious Disease Diagnostics Value Market Share by Country in 2025
Figure 26. United States Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region in 2025
Figure 31. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 33. China Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country in 2025
Figure 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. United States Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Canada Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. China Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Japan Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Korea Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. India Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Australia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Germany Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. France Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. UK Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Italy Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Russia Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Israel Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
